ATE183100T1 - Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel - Google Patents

Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel

Info

Publication number
ATE183100T1
ATE183100T1 AT92904197T AT92904197T ATE183100T1 AT E183100 T1 ATE183100 T1 AT E183100T1 AT 92904197 T AT92904197 T AT 92904197T AT 92904197 T AT92904197 T AT 92904197T AT E183100 T1 ATE183100 T1 AT E183100T1
Authority
AT
Austria
Prior art keywords
antidiabetic
antiviral
novel
inhibitors useful
pct
Prior art date
Application number
AT92904197T
Other languages
English (en)
Inventor
Robert A Farr
Norton P Peet
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of ATE183100T1 publication Critical patent/ATE183100T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/08—Six-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/567—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with sulfur as the only hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/277—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT92904197T 1991-01-10 1991-12-13 Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel ATE183100T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63963591A 1991-01-10 1991-01-10
US78420891A 1991-10-28 1991-10-28

Publications (1)

Publication Number Publication Date
ATE183100T1 true ATE183100T1 (de) 1999-08-15

Family

ID=27093368

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92904197T ATE183100T1 (de) 1991-01-10 1991-12-13 Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel

Country Status (15)

Country Link
US (1) US5438069A (de)
EP (1) EP0566666B1 (de)
JP (1) JP2951723B2 (de)
KR (1) KR100192862B1 (de)
AT (1) ATE183100T1 (de)
AU (1) AU660641B2 (de)
CA (1) CA2098927A1 (de)
DE (1) DE69131522T2 (de)
DK (1) DK0566666T3 (de)
ES (1) ES2136615T3 (de)
GR (1) GR3031423T3 (de)
IE (1) IE920087A1 (de)
NZ (1) NZ241234A (de)
PT (1) PT100001B (de)
WO (1) WO1992011867A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE126696T1 (de) * 1985-12-23 1995-09-15 Hutchinson Fred Cancer Res Regulierung der retroviralen replikation, infektion und pathogenese.
US5650413A (en) * 1995-06-07 1997-07-22 Glycodesign Inc. Derivatives of swainsonine, processes for their preparation and their use as therapeutic agents
WO1998014446A1 (en) * 1996-10-01 1998-04-09 Glycodesign Inc. Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
CA2286766A1 (en) 1997-04-15 1998-10-22 Glycodesign Inc. Alkaloid halide salts of swainsonine and methods of use
US5998485A (en) * 1997-06-16 1999-12-07 Cedars-Sinai Medical Center Method for modulating immune response with inositol
AU9617298A (en) * 1997-10-24 1999-05-17 Glycodesign Inc. Synthesis of swainsonine salts

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4205068A (en) * 1978-05-18 1980-05-27 E. R. Squibb & Sons, Inc. β-Lactamase inhibitor EM4615
EP0056194B1 (de) * 1981-01-05 1984-09-12 Takeda Chemical Industries, Ltd. N-substituierte Pseudo-Aminozucker, ihre Herstellung und Verwendung
US4399224A (en) * 1981-07-13 1983-08-16 A. E. Staley Manufacturing Company Enzymatically treated phosphatides
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
EP0104047B1 (de) * 1982-09-16 1987-07-29 Wako Pure Chemical Industries, Ltd. Modifizierte Oligosaccharide als Substrate zur Messung der alpha-Amylaseaktivität
ES2058070T3 (es) * 1986-05-09 1994-11-01 Pulverer Gerhard Utilizacion de monosacaridos especificos para la preparacion de un medicamento para impedir metastasis de tumores malignos.
US4963479A (en) * 1986-10-07 1990-10-16 Hoechst Celanese Corporation Reagent system for an alpha-amylase assay containing aromatic substituted glycoside
US4962097A (en) * 1988-10-28 1990-10-09 Merck & Co., Inc. Method of treating bacterial infection with phosphorus containing DHP enzyme inhibitors
US5032505A (en) * 1988-11-21 1991-07-16 Chembiomed, Ltd. Inhibitors for glycosaminosyl transferase V
US4988682A (en) * 1989-02-03 1991-01-29 University Of Pittsburgh Myo-inositol analogs and method for their use
US5053399A (en) * 1989-02-03 1991-10-01 University Of Pittsburgh Myo-inositol analogs and methods for their use
US5240707A (en) * 1990-04-12 1993-08-31 Merrell Dow Pharma Alpha-mannosidase and fucosidase inhibitors

Also Published As

Publication number Publication date
DE69131522T2 (de) 1999-11-25
AU9176091A (en) 1992-08-17
KR100192862B1 (ko) 1999-06-15
EP0566666A4 (en) 1994-06-08
IE920087A1 (en) 1992-07-15
JP2951723B2 (ja) 1999-09-20
CA2098927A1 (en) 1992-07-11
EP0566666A1 (de) 1993-10-27
PT100001A (pt) 1993-02-26
US5438069A (en) 1995-08-01
DK0566666T3 (da) 1999-12-06
GR3031423T3 (en) 2000-01-31
KR930703013A (ko) 1993-11-29
JPH06504550A (ja) 1994-05-26
AU660641B2 (en) 1995-07-06
ES2136615T3 (es) 1999-12-01
PT100001B (pt) 1999-06-30
WO1992011867A1 (en) 1992-07-23
DE69131522D1 (de) 1999-09-16
NZ241234A (en) 1994-07-26
EP0566666B1 (de) 1999-08-11

Similar Documents

Publication Publication Date Title
DE69115280D1 (de) Indolderivate, die die leukotrienbiosynthese hemmen.
SE9604793D0 (sv) New polymorphs
DE69431194T2 (de) Amidino-derivate nützlich als no synthase-hemmer
TR199801253T2 (xx) Vitronektin resept�r� antagonistleri.
DE69621831T2 (de) Piperazinderivative als tachykinin antagonisten
TR199901191T2 (xx) Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�.
ITMI931780A1 (it) Tropil 7-azaindolil-3-carbossiamidi
DK0937074T3 (da) Benzonaphthyridiner som bronkiale terapeutiske midler
DE69719358T2 (de) Substituierte dihydrobenzofurane als pde-hemmstoffe
PT920426E (pt) Novos derivados de tiazole com efeito inibidor de fosfodiesterase
FI973221A0 (fi) 1-aryyli-2-asyyliammo-etaaniyhdisteitä ja niiden käyttö neurokiniiniantagonisteina, erityisesti neurokiniini 1 antagonisteina
ATE183100T1 (de) Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel
NO953660D0 (no) Antrakinoner som markeringsmidler for mineraloljer
NO970341D0 (no) Imidazopyridin-azolidinoner
TR199701298T1 (xx) Tetralinler.
NO941084D0 (no) Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner
ATE180485T1 (de) Nitrone verwendbar zum abfangen von freien radikalen
ES2091039T3 (es) Nuevos bis-fenil-hexenos.
FI962301A0 (fi) Substituoidut aminoalkyyliaminopyridiinit
DK0659184T3 (da) Optisk aktivt hydroquinin-1-(3-aminophenyl)-ethansulfonat samt fremstilling og anvendelse deraf
ECSP972052A (es) Quinoxalinadionas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee